X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

THTX

Closed

Theratechnologies Inc.

2.3
-0.1 (-4.24%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.36
Day's Range: 2.29 - 2.355
Send
When Written:
 
0.8074
Theratechnologies Inc. is a biopharmaceutical company that specializes in the development and commercialization of innovative therapies for people living with HIV/AIDS. The company was founded in 1993 and is based in Montreal, Canada.

Theratechnologies’ flagship product is EGRIFTA® (tesamorelin for injection), a growth hormone-releasing factor (GRF) analog that is used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. The company also has a pipeline of other potential treatments for HIV and other medical conditions.

Theratechnologies is listed on the Toronto Stock Exchange (TSX: TH) and the NASDAQ Global Market (NASDAQ: THTX). The company has partnerships with pharmaceutical companies such as TaiMed Biologics, and has received funding from government organizations such as the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH).

Theratechnologies’ mission is to improve the lives of people living with HIV/AIDS by providing innovative therapies that address unmet medical needs.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X